No increased risk of hepatocellular carcinoma after eradication of hepatitis C virus by direct-acting antivirals, compared with interferon-based therapy (Q114024736)
Jump to navigation
Jump to search
scientific article published in 2022
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | No increased risk of hepatocellular carcinoma after eradication of hepatitis C virus by direct-acting antivirals, compared with interferon-based therapy |
scientific article published in 2022 |
Statements
No increased risk of hepatocellular carcinoma after eradication of hepatitis C virus by direct-acting antivirals, compared with interferon-based therapy (English)
1 reference
hepatitis C virus
1 reference
Namiki Izumi
1 reference
Hidenori Toyoda
1 reference
Masaaki Korenaga
1 reference
Kazumoto Murata
1 reference
Nobuharu Tamaki
1 reference
Osamu Yokosuka
1 reference
Tetsuo Takehara
1 reference
Naoya Sakamoto
1 reference
Goki Suda
1 reference
Shuhei Nishiguchi
1 reference
Hirayuki Enomoto
1 reference
Fusao Ikeda
1 reference
Mikio Yanase
1 reference
Takuya Genda
1 reference
Takeji Umemura
1 reference
Hiroshi Yatsuhashi
1 reference
Kazumi Yamasaki
1 reference
Tatsuya Ide
1 reference
Nobuo Toda
1 reference
Tatsuo Kanda
1 reference
Kazushige Nirei
1 reference
Yoshiyuki Ueno
1 reference
Hiroaki Haga
1 reference
Yoichi Nishigaki
1 reference
Kunio Nakane
1 reference
Masao Omata
1 reference
Hitoshi Mochizuki
1 reference
Yoshihiko Aoki
1 reference
Masatoshi Imamura
1 reference
Tatsuya Kanto
1 reference
31 August 2022
1 reference
4
1 reference
216-224
1 reference
4
1 reference